Dr Anna Schultze
Pharmacoepidemiology - GSK Collaboration
Anna is a pharmacoepidemiologist who joined the Electronic Health Records Group at LSHTM in 2020. Before joining LSHTM, Anna worked as a senior research associate at the consultancy firm Evidera, where she designed and managed post-authorisation safety and comparative effectiveness studies, primarily using nationwide Scandinavian health registries. She completed a PhD in epidemiology at UCL in 2017, focusing on HIV drug resistance, and also holds an MSc in Epidemiology from LSHTM and a BSc in Human Sciences from UCL.
Anna teaches on Extended Epidemiology, Basic Epidemiology and on the Professional Certificate in Pharmacoepidemiology.
Anna is interested in how we can better use routinely collected data to study the effectiveness and safety of medications. Her current research uses self-controlled study designs to study COVID-19 vaccine safety, and explores how self-controlled studies can be applied to the analyses of clinical trial extension studies. She is also involved in a number of studies on the epidemiology of COVID-19 using the OpenSAFELY platform.